An Argument for Intuitive Surgical (ISRG)
Intuitive Surgical (ISRG) is an undervalued equity whose position in the medical device industry places it for prime appreciation in the years to come. Taking a conservative estimate of 13% EPS growth (far less than current rates) and a 21 P/E (far less than historical), the stock which is presently trading in the low $90’s at a P/E of 17.7 should approach $225 by 2014. This would represent an annual appreciation of 20%.